FDA Inspection 1306760 — Community Blood Center of Greater Kansas City, an Operating Division of New York Blood Center, Inc.

Community Blood Center of Greater Kansas City, an Operating Division of New York Blood Center, Inc. — FEI 3000719449

The FDA completed an inspection of Community Blood Center of Greater Kansas City, an Operating Division of New York Blood Center, Inc. on March 2, 2026 in Blue Springs, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 2, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Blue Springs, MO (United States)